ENDRA Life Sciences share price logo

ENDRA Life Sciences

NASDAQ: NDRA

$6.31

+0.81

(+14.73%)

as on

ENDRA Life Sciences Stock Performance

as on September 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.42
    $6.30
    downward going graph

    14.10%

    Downside

    -0.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.96
    $9.85
    downward going graph

    53.09%

    Downside

    56.10%

    Upside

    downward going graph

ENDRA Life Sciences share price movements today

Previous Close
$5.50
Open
$5.49
Volume
381.3K
Market Cap
$8.2M
Day's Low - High
$5.42 - $6.30
52 Week Low - High
$2.96 - $9.85

ENDRA Life Sciences Historical Returns

1 Month Return
+ 22.49 %
3 Month Return
+ 15.55 %
1 Year Return
+ 14.82 %
3 Year Return
-99.73 %
5 Year Return
-99.99 %

ENDRA Life Sciences Stock Fundamentals & Key Indicators

Check ENDRA Life Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.2M

EPS (TTM)

-6.33

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.87

Industry PE ratio

-4.20

PEG Ratio

-0.01123401414748479

EBITDA

-7.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-224.80%

ENDRA Life Sciences Stock Valuation

Track how ENDRA Life Sciences P/E has moved over time to understand its valuation trends.

ENDRA Life Sciences in the last 5 years

  • Overview

  • Trends

Lowest (-4411.18x)

December 31, 2021

Industry (-4.20x)

March 31, 2026

Today (-0.51x)

March 31, 2026

Highest (-0.51x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: -0.51x

ENDRA Life Sciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ENDRA Life Sciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$8.2M-99.99%-0.870.00%0.00%
StrongBuy$53.2B198.62%-271.6165.30%0.00%
StrongBuy$44.1B-8.73%29.553.73%0.52%
StrongBuy$240.9B9.11%34.9940.37%0.28%
StrongBuy$147.2B-34.52%37.0458.51%0.69%

Stock Returns calculator for ENDRA Life Sciences Stock including INR - Dollar returns

The ENDRA Life Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

ENDRA Life Sciences investment value today

Current value as on today

₹1,42,924

Returns

₹42,924

(+42.92%)

Returns from ENDRA Life Sciences Stock

₹31,733 (+31.73%)

Dollar Impact

₹11,192 (+11.19%)

Analyst Recommendation on ENDRA Life Sciences Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for ENDRA Life Sciences. Average target price of $25

ENDRA Life Sciences Share Price Target

Get share price movements and forecasts by analysts on ENDRA Life Sciences.

What analysts predicted

74.76%UPSIDE

Target Price

$25

Current Price

$6.31

Analyzed by

7 Analysts

Target

$25.00

ENDRA Life Sciences target price $25, a slight upside of 74.76% compared to current price of $6.31. According to 7 analysts rating.

Indian Investors' Interest in ENDRA Life Sciences Stock

Search interest for ENDRA Life Sciences Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:37% versus previous 30 day period

ENDRA Life Sciences Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
-
Operating Income
-3
-1
-2
-2
-1
-1
-1
-1
-2
-1
EBITDA
-3
-1
-2
-2
5
0
-1
-1
-1
-1
Interest Expense
-
-
-
-
7
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-1
-2
-2
-2
-1
-1
-1
-1
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-1
-2
-2
-2
-1
-1
-1
-1
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

ENDRA Life Sciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Total Revenue
0
0
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-
-
Operating Income
-4
-9
-10
-11
-11
-13
-10
-10
-5
EBITDA
-4
-8
-10
-11
-11
-12
-9
-11
-6
Interest Expense
-
0
2
0
-
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-9
-13
-11
-11
-13
-10
-11
-7
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-5
-9
-13
-11
-11
-13
-10
-11
-7
Net Profit Margin
50.86%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

ENDRA Life Sciences Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-3
-1
-2
-2
-2
-1
-1
-1
-1
0
Operating Cash Flow
-2
-2
-2
-2
-1
-1
-1
-1
-1
0
Investing Cash Flow
-
0
0
0
-
0
-
-
0
2
Financing Cash Flow
1
1
0
7
0
0
0
0
0
3
Change in Cash
-1
0
-1
5
-1
-1
0
-1
0
5

ENDRA Life Sciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Net Income
-5
-9
-13
-11
-11
-13
-10
-11
-7
Operating Cash Flow
-3
-7
-8
-10
-11
-12
-9
-7
-5
Investing Cash Flow
0
0
0
0
0
0
0
0
-3
Financing Cash Flow
8
8
8
11
13
8
7
7
5
Change in Cash
5
0
0
1
2
-4
-2
0
-2

Mutual Funds that own ENDRA Life Sciences Stock

Check out the Mutual Funds with significant holdings in ENDRA Life Sciences.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.514855%
7722
VANGUARD INDEX FUNDS
0.187753%
2816

Global Institutional Holdings in ENDRA Life Sciences

Funds
Holdings
Vanguard
0.49%

Insights on ENDRA Life Sciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NDRA stock has moved up by 22.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 104.0% return, outperforming this stock by 89.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 681.1% return, outperforming this stock by 780.8%

About ENDRA Life Sciences

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.
OrganisationENDRA Life Sciences
Headquarters3600 Green Court, Ann Arbor, MI, 48105-1570, US
IndustryMedical - Diagnostics & Research
CEOAlexander Y. Tokman
E-voting on sharesClick here to vote

Key Management of ENDRA Life Sciences

Name

Title

Dr. Jonathan Behr Ph.D.

Co-Founder

Mr. Scott Sober

Head of Operations

Mr. Ziad Rouag J.D.

Head of Regulatory & Clinical Affairs

Mr. Idan Steinberg

Head of Engineering

Mr. Alexander Y. Tokman

CEO & Chairman

Mr. Richard Jacroux

CFO & Secretary

FAQs

What is ENDRA Life Sciences share price today?

ENDRA Life Sciences share price today is $6.31 as on at the close of the market. ENDRA Life Sciences share today touched a day high of $6.30 and a low of $5.42.

What is the 52 week high and 52 week low for ENDRA Life Sciences share?

ENDRA Life Sciences share touched a 52 week high of $9.85 on and a 52 week low of $2.96 on . ENDRA Life Sciences stock price today i.e. is closed at $6.31,which is 35.94% down from its 52 week high and 113.18% up from its 52 week low.

What is ENDRA Life Sciences's market capitalisation today?

ENDRA Life Sciences market capitalisation is $0.00T as on .

How to invest in ENDRA Life Sciences Stock (NDRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ENDRA Life Sciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ENDRA Life Sciences Shares that will get you 0.2377 shares as per ENDRA Life Sciences share price of $6.31 per share as on September 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy ENDRA Life Sciences Stock (NDRA) from India?

Indian investors can start investing in ENDRA Life Sciences (NDRA) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in ENDRA Life Sciences stock (as per the Rupee-Dollar exchange rate as on ). Based on ENDRA Life Sciences share’s latest price of $6.31 as on September 22, 2026 at 1:29 am IST, you will get 1.5848 shares of ENDRA Life Sciences. Learn more about fractional shares .

What are the returns that ENDRA Life Sciences has given to Indian investors in the last 5 years?

ENDRA Life Sciences stock has given -99.99% share price returns and 30.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?